agilon health, inc. (NYSE:AGL - Get Free Report) shares were up 9.6% on Friday . The stock traded as high as $2.12 and last traded at $2.11. Approximately 2,120,714 shares traded hands during mid-day trading, an increase of 16% from the average daily volume of 1,826,953 shares. The stock had previously closed at $1.92.
Analyst Ratings Changes
AGL has been the topic of a number of research reports. Evercore ISI dropped their target price on shares of agilon health from $7.00 to $4.00 and set an "in-line" rating on the stock in a research report on Tuesday, October 8th. Stifel Nicolaus dropped their price objective on shares of agilon health from $7.00 to $2.00 and set a "hold" rating on the stock in a report on Tuesday, November 12th. TD Cowen reduced their target price on shares of agilon health from $6.00 to $2.00 and set a "hold" rating for the company in a research note on Monday, November 11th. Royal Bank of Canada reissued an "outperform" rating and set a $3.00 target price on shares of agilon health in a research report on Tuesday, November 19th. Finally, Citigroup lowered their price objective on agilon health from $2.50 to $1.75 and set a "sell" rating on the stock in a research report on Wednesday, November 13th. Three equities research analysts have rated the stock with a sell rating, sixteen have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $4.28.
View Our Latest Analysis on agilon health
agilon health Stock Performance
The stock has a 50-day moving average of $2.11 and a 200 day moving average of $3.95. The firm has a market capitalization of $861.12 million, a P/E ratio of -2.22 and a beta of 0.51. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.
agilon health (NYSE:AGL - Get Free Report) last announced its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. During the same quarter in the previous year, the company posted ($0.06) EPS. On average, research analysts anticipate that agilon health, inc. will post -0.52 earnings per share for the current year.
Insiders Place Their Bets
In other agilon health news, Director Karen Mcloughlin purchased 25,000 shares of the stock in a transaction dated Friday, December 13th. The stock was bought at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the transaction, the director now directly owns 73,166 shares in the company, valued at $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director John William Wulf acquired 45,000 shares of the business's stock in a transaction that occurred on Thursday, December 5th. The stock was acquired at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the acquisition, the director now directly owns 206,133 shares of the company's stock, valued at $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 90,000 shares of company stock valued at $198,100. Insiders own 3.20% of the company's stock.
Institutional Trading of agilon health
Several institutional investors and hedge funds have recently made changes to their positions in the business. Point72 Asia Singapore Pte. Ltd. bought a new position in agilon health during the 3rd quarter worth approximately $28,000. City State Bank bought a new position in shares of agilon health during the third quarter worth $52,000. Allspring Global Investments Holdings LLC grew its holdings in shares of agilon health by 17,790.0% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company's stock valued at $70,000 after buying an additional 10,674 shares during the period. Signaturefd LLC increased its position in shares of agilon health by 166.2% in the 2nd quarter. Signaturefd LLC now owns 11,848 shares of the company's stock valued at $77,000 after buying an additional 7,398 shares in the last quarter. Finally, CIBC Asset Management Inc acquired a new stake in agilon health during the 2nd quarter worth $78,000.
About agilon health
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Stories
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.